New research has indicated that, for patients with multivessel coronary artery disease (blockage in three arteries), coronary artery bypass grafting (CABG) provides better survival outcomes than less-invasive percutaneous interventions (stenting). The Society of Thoracic Surgeons is strongly urging that providers reconsider practice guidelines to account for this patient population. For media, these resources provide an overview of the findings and the Society's stance:
- Press Release: Patients with Multiple Artery Blockages Undergoing Coronary Artery Bypass Surgery Fare Better, Live Longer than Those Who Opt for Stenting
- Press Release: Coronary Revascularization Guidelines Must Be Reconsidered to Account for Patients with Multivessel Disease, Surgeons Warn
- STS 2023 Plenary Session: C. Walton Lillehei Lecture by Peter K. Smith, MD (login required)
- Video: Coronary Revascularization Guideline: Why STS and AATS Did Not Endorse
- Editorial in The Annals of Thoracic Surgery (login required for full article): The American Association for Thoracic Surgery and The Society of Thoracic Surgeons Reasoning for Not Endorsing the 2021 ACC/AHA/SCAI Coronary Revascularization Guidelines
- Editor's Choice Summary by Annals Editor Joanna Chikwe, MD: Critical Times for Coronary Revascularization Guidelines
For more information, contact Charlie Simpson, SVP of Marketing and Communications.